Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy Ratner

Showing results (61-70 of 147) with videos related to

Pageof 15
Sort By:
Cancer Cell|February 5, 2008
Plexiform and dermal neurofibromas and pigmentation are caused by Nf1 loss in desert hedgehog-expressing cellsJianqiang Wu, Jon P Williams, Tilat A Rizvi, et al.
Elife|March 21, 2022
P2RY14 cAMP signaling regulates Schwann cell precursor self-renewal, proliferation, and nerve tumor initiation in a mouse model of neurofibromatosisJennifer Patritti Cram, Jianqiang Wu, Robert A Coover, et al.
Cancer Research|August 25, 2012
In vivo regulation of TGF-β by R-Ras2 revealed through loss of the RasGAP protein NF1Deanna M Patmore, Sara Welch, Patricia C Fulkerson, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 7, 2014
The protein tyrosine phosphatase Shp2 is required for the generation of oligodendrocyte progenitor cells and myelination in the mouse telencephalonLisa A Ehrman, Diana Nardini, Sarah Ehrman, et al.
Oncotarget|November 16, 2017
Immune profiling of NF1-associated tumors reveals histologic subtype distinctions and heterogeneity: implications for immunotherapyKellie B Haworth, Michael A Arnold, Christopher R Pierson, et al.
Acta Neuropathologica Communications|November 25, 2018
Tonic ATP-mediated growth suppression in peripheral nerve glia requires arrestin-PP2 and is evaded in NF1Robert A Coover, Tabitha E Healy, Li Guo, et al.
Pediatric Neurology|March 30, 2023
Motor Function and Physiology in Youth With Neurofibromatosis Type 1Alexander C Doherty, David A Huddleston, Paul S Horn, et al.
Pediatric Neurology|May 22, 2026
A Randomized, Double-Blind, Pilot Study of N-Acetylcysteine for Motor and Cognitive Symptoms in Youth With Neurofibromatosis Type 1Donald L Gilbert, Lindsey E Aschbacher-Smith, Karlee Y Migneault, et al.
American Journal of Cancer Research|April 9, 2020
Polo-like kinase 1 as a therapeutic target for malignant peripheral nerve sheath tumors (MPNST) and schwannomasJianman Guo, Katherine E Chaney, Kwangmin Choi, et al.
Pediatric Blood & Cancer|February 15, 2011
Preclincial testing of sorafenib and RAD001 in the Nf(flox/flox) ;DhhCre mouse model of plexiform neurofibroma using magnetic resonance imagingJianqiang Wu, Eva Dombi, Edwin Jousma, et al.
Pageof 15

Showing results (61-70 of 147) with videos related to

Sort By:
Pageof 15
Cancer Cell|February 5, 2008
Plexiform and dermal neurofibromas and pigmentation are caused by Nf1 loss in desert hedgehog-expressing cellsJianqiang Wu, Jon P Williams, Tilat A Rizvi, et al.
Elife|March 21, 2022
P2RY14 cAMP signaling regulates Schwann cell precursor self-renewal, proliferation, and nerve tumor initiation in a mouse model of neurofibromatosisJennifer Patritti Cram, Jianqiang Wu, Robert A Coover, et al.
Cancer Research|August 25, 2012
In vivo regulation of TGF-β by R-Ras2 revealed through loss of the RasGAP protein NF1Deanna M Patmore, Sara Welch, Patricia C Fulkerson, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 7, 2014
The protein tyrosine phosphatase Shp2 is required for the generation of oligodendrocyte progenitor cells and myelination in the mouse telencephalonLisa A Ehrman, Diana Nardini, Sarah Ehrman, et al.
Oncotarget|November 16, 2017
Immune profiling of NF1-associated tumors reveals histologic subtype distinctions and heterogeneity: implications for immunotherapyKellie B Haworth, Michael A Arnold, Christopher R Pierson, et al.
Acta Neuropathologica Communications|November 25, 2018
Tonic ATP-mediated growth suppression in peripheral nerve glia requires arrestin-PP2 and is evaded in NF1Robert A Coover, Tabitha E Healy, Li Guo, et al.
Pediatric Neurology|March 30, 2023
Motor Function and Physiology in Youth With Neurofibromatosis Type 1Alexander C Doherty, David A Huddleston, Paul S Horn, et al.
Pediatric Neurology|May 22, 2026
A Randomized, Double-Blind, Pilot Study of N-Acetylcysteine for Motor and Cognitive Symptoms in Youth With Neurofibromatosis Type 1Donald L Gilbert, Lindsey E Aschbacher-Smith, Karlee Y Migneault, et al.
American Journal of Cancer Research|April 9, 2020
Polo-like kinase 1 as a therapeutic target for malignant peripheral nerve sheath tumors (MPNST) and schwannomasJianman Guo, Katherine E Chaney, Kwangmin Choi, et al.
Pediatric Blood & Cancer|February 15, 2011
Preclincial testing of sorafenib and RAD001 in the Nf(flox/flox) ;DhhCre mouse model of plexiform neurofibroma using magnetic resonance imagingJianqiang Wu, Eva Dombi, Edwin Jousma, et al.
Pageof 15